NEW YORK ( TheStreet) -- Regeneron Pharmaceuticals (Nasdaq: REGN) hit a new 52-week high Tuesday as it is currently trading at $121.95, above its previous 52-week high of $121.55 with 140,762 shares traded as of 10:10 a.m. ET. Average volume has been 1.4 million shares over the past 30 days. Regeneron has a market cap of $7.18 billion and is part of the health care sector and drugs industry. Shares are up 116.9% year to date as of the close of trading on Monday. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter